Revance Therapeutics, Inc. (RVNC) Stock Analysis
DELISTED 2025
What happened to Revance Therapeutics, Inc. (RVNC) stock?
Revance Therapeutics, Inc. (RVNC) no longer trades on public markets. It was delisted in February 2025. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- February 2025
- Last recorded price (historical):
- $3.65 (last quote on record before the February 2025 delisting; historical, not a current quote)
Market cap $381M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Revance Therapeutics, Inc. (RVNC). Revance Therapeutics, Inc. is a biotechnology company specializing in the development and commercialization of neuromodulators for both aesthetic and therapeutic applications.
Last analyzed: Jun 15, 2026Revance Therapeutics, Inc. (RVNC) Healthcare & Pipeline Overview
More about this archive record
Can I still buy RVNC shares?
No. RVNC stopped trading on public markets in February 2025, so the shares are not available through a broker. Anything you see quoted for RVNC elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before RVNC stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Revance Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.